Targeted therapy combined with radiotherapy in non-small-cell lung cancer: a review of the Oncologic Group for the Study of Lung Cancer (Spanish Radiation Oncology Society)
Clin. transl. oncol. (Print)
; 19(1): 31-43, ene. 2017. tab
Artigo
em Inglês
| IBECS
| ID: ibc-159116
Biblioteca responsável:
ES1.1
Localização: BNCS
ABSTRACT
In recent years, major advances in our understanding of the molecular biology of lung cancer, together with significant improvements in radiotherapy technologies, have revolutionized the treatment of non-small cell lung cancer (NSCLC). This has led to the development of new therapies that target molecular mutations specific to each tumor type, acting on the cell surface antigens or intracellular signaling pathways, or directly affecting cell survival. At the same time, ablative dose radiotherapy can be delivered safely in the context of metastatic disease. In this article, the GOECP/SEOR (Oncological Group for Study of Lung Cancer/Spanish Society of Radiation Oncology) reviews the role of new targeted therapies used in combination with radiotherapy in patients with locally advanced (stage III) NSCLC and in patients with advanced, metastatic (stage IV) NSCLC (AU)
RESUMEN
No disponible
Buscar no Google
Coleções:
Bases de dados nacionais
/
Espanha
Base de dados:
IBECS
Assunto principal:
Radioterapia
/
Terapia Combinada
/
Carcinoma Pulmonar de Células não Pequenas
/
Anticorpos Monoclonais
/
Metástase Neoplásica
Limite:
Feminino
/
Humanos
/
Masculino
Idioma:
Inglês
Revista:
Clin. transl. oncol. (Print)
Ano de publicação:
2017
Tipo de documento:
Artigo
Instituição/País de afiliação:
Hospital Ruber Internacional/Spain
/
Hospital Universitario Fundación Jiménez Díaz/Spain
/
Hospital Universitario La Ribera/Spain
/
Hospital Universitario Puerta del Mar/Spain
/
Hospital Universitario Quirón/Spain
/
Hospital Universitario Santiago de Compostela/Spain
/
Hospital de la Esperanza/Spain